We incorporated the building block technique for search strategy and explored studies related to sodium-glucose cotransporter-2 inhibitors (SGLT-2i)/SGLT-2 inhibitors on cardiovascular outcomes/SGLT-2 inhibitors on renal outcomes/diabetes. This evidence concerns the gene SLC5A2 and diabetes mellitus.